Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of rifampicin crystal and preparation method thereof

A rifampicin and crystal technology, applied in the field of chemical engineering industrial crystallization, can solve the problems of small particle size, low bulk density, unable to meet the needs of users for high bulk density of medicine, etc., and achieves large crystal size, uniform distribution, and easy drying. Effect

Active Publication Date: 2016-08-24
TIANJIN UNIV
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above two crystals have the problems of small particle size and low bulk density, which cannot meet the needs of users for high bulk density of medicines.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of rifampicin crystal and preparation method thereof
  • A kind of rifampicin crystal and preparation method thereof
  • A kind of rifampicin crystal and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Take 198g of crude product of crystal form I rifampicin with a purity of 90%, take 1000mL of acetone, and prepare a rifampicin solution; stir and heat up to 55°C to dissolve the rifampicin solid, then add 100ml of water; with a cooling rate of 8°C / h When the temperature is lowered to 45.7°C, the crystals are precipitated, and then the temperature is lowered to 5°C at a cooling rate of 2°C / h, and the crystal is grown for 30 minutes; the crystal slurry is filtered and washed, and the filter cake is dried at 30°C and vacuum degree of 0.08MPa for 2 hours to obtain new The crystalline form of rifampicin product was 144.5g, and the yield was 73%.

[0032] The powder X-ray diffraction pattern of the product is as image 3 As shown, there are characteristic peaks at diffraction angles (2θ) of 5.81, 7.02, 9.09, 12.23, 14.02, 15.48, 16.46, 17.61, 19.62, 20.13, 22.38 and 24.31 degrees. IR Figure 4 Shown at 768, 892, 971, 1057, 1156, 1233, 1371, 1431, 1646, 1716, 2938, 3428, 360...

Embodiment 2

[0034] Take 100g of crude product of crystal form I rifampicin with a purity of 92%, take 1000mL of acetone, and prepare a rifampicin solution; stir and heat up to 53°C to dissolve the rifampicin solid, then add 150ml of water; When the temperature is lowered to 43°C, the crystals are precipitated, and then the temperature is lowered to 5°C at a cooling rate of 1°C / h, and the crystal is grown for 30 minutes; the crystal slurry is filtered and washed, and the filter cake is dried at 40°C and a vacuum of 0.07MPa for 1.5h. 78.8 g of the new crystal form rifampicin was obtained, with a yield of 79%.

[0035] As shown in the powder X-ray diffraction pattern of the product, there are characteristic peaks at diffraction angles (2θ) of 5.80, 7.12, 9.11, 12.18, 14.13, 15.48, 16.31, 17.52, 19.58, 20.02, 22.31 and 24.22 degrees. Infrared spectra at 767, 894, 971, 1058, 1157, 1236, 1370, 1432, 1646, 1719, 2936, 3426, 3607, 3722, 3755, 3817 and 3838cm -1 There are characteristic absorptio...

Embodiment 3

[0037] Get 200g of crude product of crystal form I rifampicin with a purity of 91%, take 1000ml of acetone, and prepare a rifampicin solution; stir and heat up to 57°C to dissolve the rifampicin solid, then add 200ml of water; Crystals precipitated when the temperature was lowered to 45.2°C, and then cooled to 5°C at a rate of 6°C / h, and the crystals were grown for 30 minutes; the crystal slurry was filtered and washed, and the filter cake was dried at 50°C and a vacuum of 0.1MPa for 0.5h to obtain The new crystal form rifampicin product is 136g, and the yield is 68%.

[0038] As shown in the powder X-ray diffraction pattern of the product, there are characteristic peaks at diffraction angles (2θ) of 5.81, 7.02, 9.23, 12.09, 14.12, 15.47, 16.53, 17.58, 19.40, 20.01, 22.32 and 24.28 degrees. Infrared spectra at 767, 893, 970, 1057, 1156, 1235, 1370, 1432, 1646, 1717, 2936, 3428, 3604, 3725, 3755, 3818 and 3836cm -1 There are characteristic peaks. The DSC spectrum has an endot...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention relates to a novel rifampin crystal form and a preparing method thereof. In a powder X-ray diffraction pattern of the novel rifampin crystal form, characteristic peaks respectively appear in the parts when diffraction angles 2 theta are 5.7 to 5.9, 6.9 to 7.1, 9.0 to 9.2, 12.1 to 12.3, 13.9 to 14.2, 15.4 to 15.6, 16.4 to 16.6, 17.5 to 17.7, 19.5 to 19.7, 20.0 to 20.2, 22.3 to 22.5, and 24.2 to 24.4. Under an agitating action, the I crystal form rifampin of which the purity is higher than or equal to 90% is dissolved in acetone at a temperature of 50-57DEG C, and 10-20 percentages by volume of water is added to the acetone. Cooling crystallizing is carried out at different cooling rates, the temperature is lowered to minus 5 DEG C to 5 DEG C, and the growth of crystals lasts for 20-40 minutes. A rifampin product in the crystal form is obtained after crystal magma is filtered, washed and dried. The indexes of the crystal product are obviously higher than those of rifampin products in other crystal forms. The rifampin product in the crystal form has great fluidity, is easy to dry and has an application value.

Description

technical field [0001] The invention belongs to the technical field of crystallization in the chemical engineering industry, and in particular relates to a new crystal form of rifampicin and a preparation method thereof, which we name as the crystal form of rifampicin III. Background technique [0002] Rifampicin, English name: Rifampicin, 3-(4-Methylpiperazinyliminomethyl)rifamycin SV; chemical name 3-[[(4-methyl-1-piperazinyl)imino]methyl]-rifamycin. Also translated as: Lifamycin, Mepirifamycin, Mepirifamycin, Weifuxian, Xian Daolun, Lifuping or Limidine. Molecular formula: C 43 h 58 N 4 o 12 , molecular weight: 822.95, CAS number: 13292-46-1. [0003] [0004] Rifampicin is brick red or dark red crystalline powder, odorless, good thermal stability, soluble in most organic solvents, slightly soluble in water, solubility in water varies with pH value. Rifampicin is a broad-spectrum semi-synthetic antibacterial drug, which can effectively kill Mycobacterium tubercul...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D498/08
CPCC07D498/08
Inventor 侯宝红井丁丁张美景王静康郝红勋鲍颖龚俊波尹秋响陈巍徐昭
Owner TIANJIN UNIV